Skip to content
Live
Trending storyDeveloping

Boltz releases open-source molecular model

1 reports1 outlets6 hours agoUpdate

The story so far

AI overview

Boltz releases open-source molecular model, allowing scientists to predict molecular interactions based on drug properties, generate specified molecules, and optimize designs. Its model has been adopted by 20 top pharmaceutical companies globally, with weekly molecular token consumption increasing by about 50 times in 4 months, and supports fine-tuning the model on proprietary data from companies like Pfizer.

AI-written from the reports · Updated 6 hours ago

Coverage timeline

Follow the coverage to see every side of the story.

18 Nov
  1. a16z News
    Investing in Boltz

    Boltz releases open-source molecular model, allowing scientists to predict molecular interactions based on drug properties, generate specified molecules, and optimize designs. Its model has been adopted by 20 top pharmaceutical companies globally, with weekly molecular token consumption increasing by about 50 times in 4 months, and supports fine-tuning the model on proprietary data from companies like Pfizer.

Heat over time

Now
8
Peak
1019 Nov, 00:00
24h change
–

Hover or tap the chart to see each hour; use the arrow keys on a keyboard.